Increasing evidence indicates that Bmi-1 is overexpressed in several cancer types, including leukemia, hepatocellular carcinoma, laryngeal carcinoma, lung cancer, breast cancer, and colon cancer [90–97]. This evidence concerns the gene BMI1 and hepatocellular carcinoma.